Clinical Trial Update: OnabotulinumtoxinA in the Management of Psychogenic Dystonia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating onabotulinumtoxinA for management of psychogenic dystonia, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystonia
• Torticollis

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University of Cincinnati | Conditions: Torticollis, Dystonia | Phase 4 | Status: COMPLETED